Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Topics in Microbiology and Immunology|April 17, 2010
CXCR4 in clinical hematologyGary Calandra, Gary Bridger, Simon Fricker
Blood|January 28, 2006
Mobilization as a preparative regimen for hematopoietic stem cell transplantationJing Chen, André Larochelle, Simon Fricker, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 27, 2003
Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavengerIrvin Mayers, Thomas Hurst, Anna Radomski, et al.
Blood|January 28, 2006
AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primatesAndré Larochelle, Allen Krouse, Mark Metzger, et al.
Blood|August 18, 2005
Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation modelLauri Burroughs, Marco Mielcarek, Marie-Térèse Little, et al.
Cancer Research|October 18, 2002
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancerChris J Scotton, Julia L Wilson, Kate Scott, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 ReplicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2011
Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Journal of Medicinal Chemistry|October 5, 2013
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Pageof 1